PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients
2026-07-24T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
ArkBio Completes all Cohort Dosing in Australian Phase I Trial with Influenza AFC Drug AK0406
2026-07-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth
2026-07-24T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Fapon Showcases AI-Engineered Enzymes and Alzheimer's Solutions at ADLM 2026, Reinforcing North American Commitment
2026-07-24T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
AH-008 Achieves Key Clinical Milestone with Successful First Subject First Dose (FSFD) in Phase I Study for Prevention of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
2026-07-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NYSE Content Update: Fourth Annual AI x Bio Summit to Commence at the NYSE
2026-07-23T    Banking/Financial Service   Biotechnology   Computer/Electronics 
PUBLIC TRUST IN HEALTH INNOVATION IS SHAPED MORE BY MINDSET THAN DEMOGRAPHICS, DNV RESEARCH FINDS
2026-07-23T    Biotechnology   Health Care/Hospital   Infectious Disease Control 
Moa Technology raises Series C round co-led by Oxford Science Enterprises and Supernova Invest
2026-07-23T    Agriculture   Biotechnology   Chemical   Computer/Electronics 
Haisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH
2026-07-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
GHIT Fund Invests Approx. JPY 140 Million in a Portable Rapid Diagnostic System for Ebola Disease in a Joint Project Between Osaka Metropolitan University, K.K. DNAFORM, and INRB
2026-07-23T    Banking/Financial Service   Biotechnology   Health Care/Hospital   Infectious Disease Control 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.